Cited by 420

The DOI matches its Crossref record; 334 of the 334 references it cites were found in a registry or an index.

Guidelines for the management of chronic kidney disease

Open access

Levin, A., Hemmelgarn, B., Culleton, B., Tobe, S., McFarlane, P., Ruzicka, M., Burns, K., Manns, B., White, C., Madore, F., Moist, L., Klarenbach, S., Barrett, B., Foley, R., Jindal, K., Senior, P., Pannu, N., Shurraw, S., Akbari, A., Cohn, A., Reslerova, M., Deved, V., Mendelssohn, D., Nesrallah, G., Kappel, J., Tonelli, M., for the Canadian Society of Nephrology·2008·Canadian Medical Association Journal

DOI 10.1503/cmaj.080351

Open this paper in CoChat — free account

Abstract

New guidelines for the management of chronic kidney disease have been developed by the Canadian Society of Nephrology (Appendix 1 contains the full-text guidelines; available at [www.cmaj.ca/cgi/content/full/179/11/1154/DC1][1]). These guidelines describe key aspects of the management of chronic

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1503/cmaj.080351

Cites

334 of 334 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Items 201–334 of 334

Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria
Rossing, K., Schjoedt, K. J., Jensen, B. R., Boomsma, F., & Parving, H.-H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00511.x · Cited by 225
Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function
Radtke, H., Claussner, A., Erbes, P., Scheuermann, E., Schoeppe, W., & Koch, K. (1979) · Blood · doi:10.1182/blood.v54.4.877.877 · Cited by 224
Prevalence of Low Glomerular Filtration Rate in Nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III)
Clase, C. M., Garg, A. X., & Kiberd, B. A. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000013291.78621.26 · Cited by 223
Lactic Acidosis Rates in Type 2 Diabetes
Brown, J. B., Pedula, K., Barzilay, J., Herson, M. K., & Latare, P. (1998) · Diabetes Care · doi:10.2337/diacare.21.10.1659 · Cited by 223
Effects of Early and Late Intervention with Epoetin α on Left Ventricular Mass among Patients with Chronic Kidney Disease (Stage 3 or 4): Results of a Randomized Clinical Trial
Roger, S. D., McMahon, L. P., Clarkson, A., Disney, A., Harris, D., Hawley, C., Healy, H., Kerr, P., Lynn, K., Parnham, A., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000102471.89084.8b · Cited by 216
Self-citation
Reviews: Use of Insulin and Oral Hypoglycemic Medications in Patients with Diabetes Mellitus and Advanced Kidney Disease
Snyder, R. W., & Berns, J. S. (2004) · Seminars in Dialysis · doi:10.1111/j.0894-0959.2004.17346.x · Cited by 215
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
Schjoedt, K. J., Rossing, K., Juhl, T. R., Boomsma, F., Tarnow, L., Rossing, P., & Parving, H. H. (2006) · Kidney International · doi:10.1038/sj.ki.5001580 · Cited by 215
Predialysis psychoeducational intervention and coping styles influence time to dialysis in chronic kidney disease
Devins, G. M., Mendelssohn, D. C., Barré, P. E., & Binik, Y. M. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00835-7 · Cited by 214
Self-citation
Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study)
Qunibi, W. Y., Hootkins, R. E., McDowell, L. L., Meyer, M. S., Simon, M., Garza, R. O., Pelham, R. W., Cleveland, M. V. B., Muenz, L. R., He, D. Y., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00590.x · Cited by 212
Predialysis Psychoeducational Intervention Extends Survival in CKD: A 20-Year Follow-Up
Devins, G. M., Mendelssohn, D. C., Barré, P. E., Taub, K., & Binik, Y. M. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.08.017 · Cited by 211
Self-citation
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: Biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
Baigent, C., Landray, M., Leaper, C., Altmann, P., Armitage, J., Baxter, A., Cairns, H. S., Collins, R., Foley, R. N., Frighi, V., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.11.015 · Cited by 210
Self-citation
Lipids and the kidney
Keane, W. F. (1994) · Kidney International · doi:10.1038/ki.1994.349 · Cited by 209
Comparative Tolerability Profiles of Oral Antidiabetic Agents
Krentz, A. J., Ferner, R. E., & Bailey, C. J. (1994) · Drug Safety · doi:10.2165/00002018-199411040-00002 · Cited by 209
Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
Rossing, K., Christensen, P. K., Jensen, B. R., & Parving, H.-H. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.95 · Cited by 205
The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes
Curtis, B. M., Ravani, P., Malberti, F., Kennett, F., Taylor, P. A., Djurdjev, O., & Levin, A. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh585 · Cited by 202
Self-citation
When to initiate dialysis: effect of proposed US guidelines on survival
Korevaar, J. C., Jansen, M. A., Dekker, F. W., Jager, K. J., Boeschoten, E. W., Krediet, R. T., & Bossuyt, P. M. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06180-3 · Cited by 201
The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide
Buter, H. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.7.1682 · Cited by 199
Canadian Randomized Trial of Hemoglobin Maintenance to Prevent or Delay Left Ventricular Mass Growth in Patients With CKD
Levin, A., Djurdjev, O., Thompson, C., Barrett, B., Ethier, J., Carlisle, E., Barre, P., Magner, P., Muirhead, N., Tobe, S., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.08.007 · Cited by 196
Self-citation
Metformin and lactic acidosis: cause or coincidence? A review of case reports
Stades, A. M. E., Heikens, J. T., Erkelens, D. W., Holleman, F., & Hoekstra, J. B. L. (2004) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01271.x · Cited by 196
Contraindications to metformin therapy in patients with Type 2 diabetes—a population‐based study of adherence to prescribing guidelines
Emslie‐Smith, A. M., Boyle, D. I. R., Evans, J. M. M., Sullivan, F., Morris, A. D., & for the DARTS/MEMO Collaboration (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00509.x · Cited by 194
Why patients with ESRD do not select self-care dialysis as a treatment option
McLaughlin, K., Manns, B., Mortis, G., Hons, R. B., & Taub, K. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50047 · Cited by 194
Self-citation
Lipid and Blood Pressure Treatment Goals for Type 1 Diabetes
Orchard, T. J., Forrest, K. Y.-Z., Kuller, L. H., & Becker, D. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1053 · Cited by 192
Impact of Glycemic Control on Survival of Diabetic Patients on Chronic Regular Hemodialysis
Oomichi, T., Emoto, M., Tabata, T., Morioka, T., Tsujimoto, Y., Tahara, H., Shoji, T., & Nishizawa, Y. (2006) · Diabetes Care · doi:10.2337/dc05-1887 · Cited by 191
Frequent Hemodialysis Network (FHN) randomized trials: Study design
Suri, R. S., for the Frequent Hemodialysis Network (FHN) Trail Group, Garg, A. X., Chertow, G. M., Levin, N. W., Rocco, M. V., Greene, T., Beck, G. J., Gassman, J. J., Eggers, P. W., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002032 · Cited by 188
Impact of Ergocalciferol Treatment of Vitamin D Deficiency on Serum Parathyroid Hormone Concentrations in Chronic Kidney Disease
Zisman, A. L., Hristova, M., Ho, L. T., & Sprague, S. M. (2007) · American Journal of Nephrology · doi:10.1159/000098561 · Cited by 187
Association between Multidisciplinary Care and Survival for Elderly Patients with Chronic Kidney Disease
Hemmelgarn, B. R., Manns, B. J., Zhang, J., Tonelli, M., Klarenbach, S., Walsh, M., & Culleton, B. F. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080860 · Cited by 186
Self-citation
Role of Metformin Accumulation in Metformin-Associated Lactic Acidosis
Lalau, J. D., Lacroix, C., Compagnon, P., Cagny, B. D., Rigaud, J. P., Bleichner, G., Chauveau, P., Dulbecco, P., Guérin, C., Haegy, J. M., et al. (1995) · Diabetes Care · doi:10.2337/diacare.18.6.779 · Cited by 185
Renal hemodialysis patients: oral, salivary, dental and periodontal findings in 105 adult cases
Gavaldá, C., Bagán, J., Scully, C., Silvestre, F., Milián, M., & Jiménez, Y. (1999) · Oral Diseases · doi:10.1111/j.1601-0825.1999.tb00093.x · Cited by 184
Association of High Serum Creatinine and Anemia Increases the Risk of Coronary Events: Results from the Prospective Community-Based Atherosclerosis Risk in Communities (ARIC) Study
Jurkovitz, C. T., Abramson, J. L., Vaccarino, L. V., Weintraub, W. S., & McClellan, W. M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000092138.65211.71 · Cited by 184
Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival
Williams, M. E., Lacson, E., Teng, M., Ofsthun, N., & Lazarus, J. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001789 · Cited by 181
The Cost of Diabetes Type II in Europe The CODE-2 Study
Massi‐Benedetti, M. (2002) · Diabetologia · doi:10.1007/s00125-002-0860-3 · Cited by 179
Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial
Miskulin, D. C., Athienites, N. V., Yan, G., Martin, A. A., Ornt, D. B., Kusek, J. W., Meyer, K. B., Levey, A. S., & for the Hemodialysis (HEMO) Study Group (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00954.x · Cited by 179
Cause-Specific Mortality in a Population With Diabetes
Roper, N. A., Bilous, R. W., Kelly, W. F., Unwin, N. C., & Connolly, V. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.43 · Cited by 179
Facilitating Advance Care Planning for Patients with End-Stage Renal Disease: The Patient Perspective
Davison, S. N. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01050306 · Cited by 176
Daily Hemodialysis: A Systematic Review
Suri, R. S., Nesrallah, G. E., Mainra, R., Garg, A. X., Lindsay, R. M., Greene, T., & Daugirdas, J. T. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00340705 · Cited by 173
Self-citation
Impact of Timing of Initiation of Dialysis on Mortality
Beddhu, S., Samore, M. H., Roberts, M. S., Stoddard, G. J., Ramkumar, N., Pappas, L. M., & Cheung, A. K. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000080184.67406.11 · Cited by 173
Evaluation of Prescribing Practices: Risk of Lactic Acidosis With Metformin Therapy
Calabrese, A. T., Coley, K. C., DaPos, S. V., Swanson, D., & Rao, R. H. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.4.434 · Cited by 170
Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension
Williams, G. H., Burgess, E., Kolloch, R. E., Ruilope, L. M., Niegowska, J., Kipnes, M. S., Roniker, B., Patrick, J. L., & Krause, S. L. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.01.007 · Cited by 166
1,25(OH)2D3 administration in moderate renal failure: A prospective double-blind trial
Baker, L. R. I., Abrams, S. M. L., Roe, C. J., Faugere, M.-C., Fanti, P., Subayti, Y., & Malluche, H. H. (1989) · Kidney International · doi:10.1038/ki.1989.36 · Cited by 165
Effects of Recombinant Human Erythropoietin on Renal Function in Chronic Renal Failure Predialysis Patients
Roth, D., Smith, R. D., Schulman, G., Steinman, T. I., Hatch, F. E., Rudnick, M. R., Sloand, J. A., Freedman, B. I., Williams, W. W., Shadur, C. A., et al. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80671-8 · Cited by 164
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter, E. E. (2006) · The Cochrane Database of Systematic Reviews (Complete Reviews) · doi:10.1002/14651858.cd002967.pub2 · Cited by 163
Reduced Cardiovascular Morbidity and Mortality Associated With Metformin Use in Subjects With Type 2 Diabetes
Johnson, J. A., Simpson, S. H., Toth, E. L., & Majumdar, S. R. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01448.x · Cited by 161
The oral health status of dentate patients with chronic renal failure undergoing dialysis therapy
Bots, C. P., Poorterman, J., Brand, H. S., Kalsbeek, H., van Amerongen, B. M., Veerman, E. C. I., & Amerongen, A. V. N. (2006) · Oral Diseases · doi:10.1111/j.1601-0825.2005.01183.x · Cited by 161
Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients
Chang, J. W., Yang, W. S., Min, W. K., Lee, S. K., Park, J. S., & Kim, S. B. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.33393 · Cited by 161
Salt Intake and Renal Outcome in Patients with Progressive Renal Disease
Cianciaruso, B., Bellizzi, V., Minutolo, R., A, T., Capuano, A., Conte, G., & Nicola, L. D. (1998) · Mineral and Electrolyte Metabolism · doi:10.1159/000057385 · Cited by 155
Nephrologists’ Reported Preparedness for End-of-Life Decision-Making
Davison, S. N., Jhangri, G. S., Holley, J. L., & Moss, A. H. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02040606 · Cited by 154
Impact of Arterial Blood Pressure and Albuminuria on the Progression of Diabetic Nephropathy in IDDM Patients
Rossing, P. R., Hommel, E. E., Smidt, U., & Parving, H. (1993) · Diabetes · doi:10.2337/diab.42.5.715 · Cited by 152
Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension
Regalado, M., Song, Y., & Wesson, D. E. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70017-5 · Cited by 149
Effects of Body-Weight Loss and Captopril Treatment on Proteinuria Associated with Obesity
Praga, M., Hernández, E., Andrés, A., León, M., Ruilope, L. M., & Rodicio, J. L. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000188541 · Cited by 148
Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan
Iseki, K., Kinjo, K., Iseki, C., & Takishita, S. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.07.007 · Cited by 147
Comparative mortality of hemodialysis and peritoneal dialysis in Canada
Murphy, S. W., Foley, R. N., Barrett, B. J., Kent, G. M., Morgan, J. M., Barré, P. E., Campbell, P., Fine, A., Goldstein, M. B., Handa, S., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00017.x · Cited by 147
Self-citation
Superior Patient Survival for Continuous Ambulatory Peritoneal Dialysis Patients Treated with a Peritoneal Dialysis Fluid with Neutral pH and Low Glucose Degradation Product Concentration (Balance)
Lee, H. Y., Park, H. C., Seo, B. J., Do, J. Y., Yun, S.-R., Song, H. Y., Kim, Y. H., Kim, Y.-L., Kim, D. J., Kim, Y., et al. (2005) · Peritoneal Dialysis International · doi:10.1177/089686080502500308 · Cited by 147
Additional Antiproteinuric Effect of Ultrahigh Dose Candesartan
Schmieder, R. E., Klingbeil, A. U., Fleischmann, E. H., Veelken, R. A., & Delles, C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005020138 · Cited by 147
Target Level for Hemoglobin Correction in Patients With Diabetes and CKD: Primary Results of the Anemia Correction in Diabetes (ACORD) Study
Ritz, E., Laville, M., Bilous, R., O'Donoghue, D. J., Scherhag, A. W., Burger, U., & de Álvaro, F. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.11.032 · Cited by 145
Statin Safety: Lessons from New Drug Applications for Marketed Statins
Jacobson, T. A. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.009 · Cited by 144
Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance
Vedovato, M., Lepore, G., Coracina, A., Dodesini, A. R., Jori, E., Tiengo, A., Prato, S. D., & Trevisan, R. (2003) · Diabetologia · doi:10.1007/s00125-003-1303-5 · Cited by 144
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II – Therapy
Khan, N. A., McAlister, F. A., Rabkin, S. W., Padwal, R. S., Feldman, R. D., Campbell, N. R. C., Leiter, L. A., Lewanczuk, R. Z., Schiffrin, E. L., Hill, M. D., et al. (2006) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(06)70280-x · Cited by 143
Self-citation
Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications
Rachmani, R., Slavachevski, I., Levi, Z., Zadok, B.-S., Kedar, Y., & Ravid, M. (2002) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(02)00131-0 · Cited by 134
Association between Smoking and Chronic Renal Failure in a Nationwide Population-Based Case-Control Study
Ejerblad, E., Fored, C. M., Lindblad, P., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000135048.35659.10 · Cited by 134
Contra‐indications to metformin therapy are largely disregarded
Holstein, A., Nahrwold, D. A., Hinze, S., & EGBERTS, E. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00115.x · Cited by 133
Influence of Erythropoietin Treatment on Hemoglobin A1c Levels in Patients with Chronic Renal Failure on Hemodialysis.
Nakao, T., Matsumoto, H., OKADA, T., Han, M., Hidaka, H., Yoshino, M., Shino, T., Yamada, C., & Nagaoka, Y. (1998) · Internal Medicine · doi:10.2169/internalmedicine.37.826 · Cited by 132
Renal Palliative Care
Cohen, L. M., Moss, A. H., Weisbord, S. D., & Germain, M. J. (2006) · Journal of Palliative Medicine · doi:10.1089/jpm.2006.9.977 · Cited by 132
A Low-Sodium Diet Potentiates the Effects of Losartan in Type 2 Diabetes
Houlihan, C. A., Allen, T. J., Baxter, A. L., Panangiotopoulos, S., CASLEY, D. J., Cooper, M. E., & Jerums, G. (2002) · Diabetes Care · doi:10.2337/diacare.25.4.663 · Cited by 132
Peer Mentoring: A Culturally Sensitive Approach to End-of-Life Planning for Long-Term Dialysis Patients
Perry, E., Swartz, J., Brown, S., Smith, D., Kelly, G., & Swartz, R. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.03.018 · Cited by 131
Lactic acidosis in metformin therapy: searching for a link with metformin in reports of ‘metformin‐associated lactic acidosis’
Lalau, J., & Race, J.-M. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00128.x · Cited by 131
Comparison of Intravenous Iron Sucrose to Oral Iron in the Treatment of Anemic Patients with Chronic Kidney Disease Not on Dialysis
Charytan, C., Qunibi, W. Y., & Bailie, G. R. (2005) · Nephron Clinical Practice · doi:10.1159/000085049 · Cited by 129
The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy
Rodby, R. A., Rohde, R. D., Sharon, Z., Pohl, M. A., Bain, R. P., & Lewis, E. J. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90054-3 · Cited by 128
Clinical Outcomes in the Diabetes Cohort of the International Verapamil SR-Trandolapril Study
Bakris, G. L., Gaxiola, E., Messerli, F. H., Mancia, G., Erdine, S. E., Cooper‐DeHoff, R. M., & Pepine, C. J. (2004) · Hypertension · doi:10.1161/01.hyp.0000143851.23721.26 · Cited by 127
Alcohol Consumption and the Risk of Renal Dysfunction in Apparently Healthy Men
Schäeffner, E., Kurth, T., de Jong, P. E., Glynn, R. J., Buring Julie, E., & Gaziano, J. M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.9.1048 · Cited by 126
A Computer Simulation Model of Diabetes Progression, Quality of Life, and Cost
Zhou, H., Isaman, D. J. M., Messinger, S., Brown, M. B., Klein, R., Brändle, M., & Herman, W. H. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2856 · Cited by 126
The Creation of an Advance Care Planning Process for Patients With ESRD
Davison, S. N., & Torgunrud, C. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.09.016 · Cited by 122
Low protein diets delay end‐stage renal disease in non‐diabetic adults with chronic renal failure
Fouque, D. P., Wang, P., Laville, M., & Boissel, J. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.12.1986 · Cited by 118
Low protein diets for chronic kidney disease in non diabetic adults
Fouque, D. P., Laville, M., & Boissel, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001892.pub2 · Cited by 118
Deterioration in renal function associated with fibrate therapy.
Lipscombe, J., Lewis, G. F., Cattran, D. C., & Bargman, J. M. (2001) · PubMed · Cited by 111
1999 Canadian recommendations for the management of hypertension
Feldman, R. D., Campbell, N. R. C., Larochelle, P. M., Bolli, P., Burgess, E. D., Carruthers, S. G., Floras, J. S., Haynes, R. B., Honos, G. N., Leenen, F. H. H., et al. (1999) · Europe PMC (PubMed Central) · Cited by 110
Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators.
Levin, S. R., Coburn, J. W., Abraira, C., Henderson, W. G., Colwell, J. A., Emanuele, N., Nuttall, F. Q., Sawin, C. T., Comstock, J. P., & Silbert, C. K. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1478 · Cited by 110
Exercise Training and the Progression of Chronic Renal Failure
Eidemak, I., Haaber, A. B., Feldt‐Rasmussen, B., Kanstrup, I., & Strandgaard, S. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000189497 · Cited by 108
Gemfibrozil for secondary prevention of cardiovascular events in mild to moderate chronic renal insufficiency
Tonelli, M. A., Collins, D. E., Robins, S. J., Bloomfield, H. E., & Curhan, G. C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00862.x · Cited by 105
Self-citation
Does urinary tract infection cause proteinuria or microalbuminuria? A systematic review
Carter, J. L., Tomson, C., Stevens, P. E., & Lamb, E. J. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl373 · Cited by 101
Supportive care for the renal patient
Levy, J. B., Chambers, E. J., & Brown, E. A. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh178 · Cited by 100
Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial
Pijls, L., de Vries, H., EIJK, J. V., & Donker, A. J. M. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601474 · Cited by 99
Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients
Kronenberg, F., Lingenhel, A., Neyer, U., Lhotta, K., König, P., Auinger, M., Wiesholzer, M., Andersson, H., & Dieplinger, H. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s84.23.x · Cited by 98
Pharmacokinetics of Oral Antihyperglycaemic Agents in Patients with Renal Insufficiency
Harrower, A. D. B. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631020-00003 · Cited by 97
Lowest Systolic Blood Pressure Is Associated with Stroke in Stages 3 to 4 Chronic Kidney Disease
Weiner, D. E., Tighiouart, H., Levey, A. S., Elsayed, E. F., Griffith, J. L., Salem, D. N., & Sarnak, M. J. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080858 · Cited by 95
Lactic Acidosis in Metformin Therapy
Lalau, J., & Race, J. (1999) · Drugs · doi:10.2165/00003495-199958001-00013 · Cited by 94
Predictive value of nutritional markers (albumin, creatinine, cholesterol, and hematocrit) for patients on dialysis for up to 30 years
Avram, M. M., Bonomini, L., Sreedhara, R., & Mittman, N. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90394-7 · Cited by 94
Adjustment for Comorbidity in Studies on Health Status in ESRD Patients: Which Comorbidity Index to Use?
van Manen, J. G., Korevaar, J. C., Dekker, F. W., Boeschoten, E. W., Bossuyt, P. M., & Krediet, R. T. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000043902.30577.c9 · Cited by 90
The 2004 Canadian recommendations for the management of hypertension: Part III--Lifestyle modifications to prevent and control hypertension.
Touyz, R. M., Campbell, N. R. C., Logan, A. G., Gledhill, N., Petrella, R. J., & Padwal, R. S. (2004) · PubMed · Cited by 89
The effect of obesity on glycaemic response to metformin or sulphonylureas in Type 2 diabetes
Donnelly, L. A., Doney, A. S. F., Hattersley, A. T., Morris, A. D., & Pearson, E. R. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01755.x · Cited by 88
Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis
Saltissi, D., Morgan, C., Rigby, R., & Westhuyzen, J. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.30547 · Cited by 86
Apolipoprotein B-containing lipoproteins in renal failure: The relation to mode of dialysis
Attman, P., Samuelsson, O. G., Moberly, J. B., Johansson, A., Ljungman, S., Weiss, L. G., Knight‐Gibson, C., & Alaupovic, P. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00375.x · Cited by 85
The Initiating Dialysis Early and Late (Ideal) Study: Study Rationale and Design
Cooper, B. A., Branley, P., Bulfone, L., Collins, J. F., Craig, J. C., Dempster, J., Fraenkel, M. B., Harris, A., Harris, D. C. H., Johnson, D. W., et al. (2004) · Peritoneal Dialysis International · doi:10.1177/089686080402400209 · Cited by 84
A randomized trial of low-protein diet in type 1 and in type 2 diabetes mellitus patients with incipient and overt nephropathy
Dussol, B., Iovanna, C., Raccah, D., Darmon, P., Morange, S., Vague, P., Vialettes, B., Oliver, C., Loundoun, A., & Berland, Y. (2005) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2005.07.003 · Cited by 84
A Previously Undescribed Side Effect of Icodextrin: Overestimation of Glycemi a by Glucose Analyzer
Wens, R., Taminne, M., Devriendt, J., Collart, F., Broeders, N., Mestrez, F., Germanos, H., & Dratwa, M. (1998) · Peritoneal Dialysis International · doi:10.1177/089686089801800608 · Cited by 82
Effect of rosuvastatin on outcomes in chronic haemodialysis patients – design and rationale of the AURORA study
Fellström, B., Zannad, F. M., Schmieder, R. E., Holdaas, H., Jardine, A. G., Rose, H., Wilpshaar, W., & the AURORA Study Group (2005) · Current Controlled Trials in Cardiovascular Medicine · doi:10.1186/1468-6708-6-9 · Cited by 81
Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.
(1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7122616 · Cited by 79
The cost-effectiveness of maintaining higher hemoglobin targets with erythropoietin in hemodialysis patients
Tonelli, M. A., Winkelmayer, W. C., Jindal, K. K., Owen, W. F., & Manns, B. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00079.x · Cited by 78
Self-citation
Prevalence of, and Risk Factors for, Angiographically Determined Coronary Artery Disease in Type I-Diabetic Patients With Nephropathy
Manske, C. L. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.12.2450 · Cited by 78
Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure
Rix, M., Eskildsen, P. C., & Ølgaard, K. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg595 · Cited by 77
Metformin's contraindications should be contraindicated
McCormack, J. P., Johns, K., & Tildesley, H. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045292 · Cited by 76
A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States
Manns, B., Stevens, L., Miskulin, D. C., Owen, W. F., Winkelmayer, W. C., & Tonelli, M. A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00877.x · Cited by 74
Self-citation
A placebo-controlled trial examining atorvastatin in dyslipidemic patients undergoing CAPD
Harris, K. P. G., Wheeler, D. C., Chong, C., & the Atorvastatin in CAPD Study Investigators (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00262.x · Cited by 74
Evaluation of diagnostic reliability of DCA 2000 for rapid and simple monitoring of HbA1c
Arsie, M. P., Marchioro, L., Lapolla, A., Giacchetto, G., Bordin, M. R., Rizzotti, P., & Fedele, D. (2000) · Acta Diabetologica · doi:10.1007/s005920070028 · Cited by 72
CADAVERIC VERSUS LIVING DONOR KIDNEY TRANSPLANTATION: A Medicare Payment Analysis 1
Smith, C. R., Woodward, R. S., Cohen, D. S., Singer, G. G., Brennan, D. C., Lowell, J. A., Howard, T. K., & Schnitzler, M. A. (2000) · Transplantation · doi:10.1097/00007890-200001270-00020 · Cited by 71
Statins for Treatment of Dyslipidemia in Chronic Kidney Disease
Shurraw, S., & Tonelli, M. A. (2006) · Peritoneal Dialysis International · doi:10.1177/089686080602600503 · Cited by 71
Self-citation
Meta-Analysis of Biochemical and Patient-Level Effects of Calcimimetic Therapy
Strippoli, G. F., Palmer, S. C., Tong, A., Elder, G. J., Messa, P., & Craig, J. C. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.01.015 · Cited by 69
Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease
Sawaya, B. P., Butros, R., Naqvi, S., Geng, Z., Mawad, H. W., Friedler, R. M., Fanti, P., Monier‐Faugere, M., & Malluche, H. H. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00129.x · Cited by 68
Costs of Diabetes
Pagano, E., Brunetti, M., Tediosi, F., & Garattini, L. (1999) · PharmacoEconomics · doi:10.2165/00019053-199915060-00006 · Cited by 65
Sustained effect of intensive treatment of type 1 diabetes mellitus on the development and progression of diabetic nephropathy in epidemiology of diabetes interventions and complications (EDIC) study.
Steffes, M. W., Molitch, M. E., Chavers, B. M., Cleary, P. A., & Lachin, J. M. (2003) · JAMA · Cited by 65
PSYCHOSOCIAL FACTORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: Palliative Care in End‐Stage Renal Disease: Focus on Advance Care Planning, Hospice Referral, and Bereavement
Holley, J. L. (2005) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2005.18208.x · Cited by 63
Lipid Parameters Including Lipoprotein (A) in Patients Undergoing CAPD and Hemodialysis
Siamopoulos, K. C., Elisaf, M., Bairaktari, H. T., Pappas, M. B., Sferopoulos, G., & Nikolakakis, N. G. (1995) · Peritoneal Dialysis International · doi:10.1177/089686089501500410 · Cited by 63
Proteinuria: Pathophysiology, Significance and Recommendations for Measurement in Clinical Practice
Beetham, R., & Cattell, W. R. (1993) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329303000502 · Cited by 57
Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease
Tonelli, M., Collins, D., Robins, S., Bloomfield, H., & Curhan, G. C. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)01082-0 · Cited by 56
Self-citation
Nutrition counseling impacts serum albumin levels
Akpele, L., & Bailey, J. L. (2004) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2004.04.003 · Cited by 56
Attitudes of Canadian Nephrologists Toward Multidisciplinary Team–Based CKD Clinic Care
Mendelssohn, D. C., Toffelmire, E. B., & Levin, A. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.019 · Cited by 56
Self-citation
Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25‐hydroxyvitamin D in chronic kidney disease
DeVille, J., Thorp, M. L., Tobin, L., Gray, E., Johnson, E. S., & Smith, D. H. (2006) · Nephrology · doi:10.1111/j.1440-1797.2006.00698.x · Cited by 49
Low-dose atorvastatin in severe chronic kidney disease patients: A randomized, controlled endpoint study
Stegmayr, B. G., Brännström, M., Bucht, S., Crougneau, V., Dimény, E., Ekspong, A., Eriksson, M., Granroth, B., Gröntoft, K., Hadimeri, H., et al. (2005) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590500329304 · Cited by 47
Nephropathy is delayed by intensified insulin treatment in patients with insulin‐dependent diabetes mellitus and retinopathy*
Reichard, P., & Rosenqvist, U. (1989) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1989.tb01359.x · Cited by 43
Alterations in Lipoprotein Composition in Peritoneal Dialysis Patients
Moberly, J. B., Attman, P., Samuelsson, O. G., Johansson, A., Knight‐Gibson, C., & Alaupovic, P. (2002) · Peritoneal Dialysis International · doi:10.1177/089686080202200209 · Cited by 43
End-of-life care in end-stage renal disease: renal and palliative care
Murtagh, F. E., Murphy, E., Shepherd, K., Donohoe, P., & Edmonds, P. (2006) · British Journal of Nursing · doi:10.12968/bjon.2006.15.1.20301 · Cited by 42
A Dipstick Protein and Specific Gravity Algorithm Accurately Predicts Pathological Proteinuria
Constantiner, M., Sehgal, A. R., Humbert, L., Constantiner, D., Arce, L., Sedor, J. R., & Schelling, J. R. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.02.012 · Cited by 42
Use of urine albumin measurement as a replacement for total protein.
Dj, N., Thakkar, H., Medcalf, E. A., Mr, G., & Cp, P. (1995) · PubMed · Cited by 42
Clinical Pharmacists as Multidisciplinary Health Care Providers in the Management of CKD: A Joint Opinion by the Nephrology and Ambulatory Care Practice and Research Networks of the American College of Clinical Pharmacy
Joy, M. S., DeHart, R. M., Gilmartin, C., Hachey, D. M., Hudson, J. Q., Pruchnicki, M. C., Dumo, P., Grabe, D. W., Saseen, J. J., & Zillich, A. J. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.02.027 · Cited by 36
Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study
Lins, R. L., Matthys, K. E., Billiouw, J.-M., Dratwa, M., Dupont, P., Lameire, N. H., Peeters, P. C., Stolear, J.-C., Tielemans, C. L., Maes, B., et al. (2004) · Clinical Nephrology · doi:10.5414/cnp62287 · Cited by 35
Glycemic control and the risk of multiple microvascular diabetic complications.
Schellhase, K. G., Koepsell, T. D., & Weiss, N. S. (2005) · PubMed · Cited by 34
Nephrology: 4. Strategies for the care of adults with chronic kidney disease.
Stigant, C. E., Stevens, L., & Levin, A. (2003) · Europe PMC (PubMed Central) · Cited by 30
Self-citation
Effects of pulsatile intravenous insulin therapy on the progression of diabetic nephropathy
DAILEY, G. E., Boden, G. H., Creech, R. H., Johnson, D. G., Gleason, R. E., Kennedy, F. P., Weinrauch, L. A., Weir, M. R., & D’Elia, J. A. (2000) · Metabolism · doi:10.1053/meta.2000.17700 · Cited by 30
Atorvastatin in Patients With Type 2 Diabetes Mellitus Undergoing Hemodialysis
Adler, S. G. (2006) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70449-8 · Cited by 29
CORE CURRICULUM IN NEPHROLOGY Palliative Care
Moss, A. H., Holley, J. L., Davison, S. N., Dart, R. A., Germain, M. J., Cohen, L. M., & Swartz, R. D. (2004) · Cited by 26
Factors affecting hypoglycemia awareness in insulin-treated type 2 diabetes
Murata, G. H., Duckworth, W. C., Shah, J. H., Wendel, C. S., & Hoffman, R. M. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.11.013 · Cited by 25
Effects of Three Treatment Modes on Plasma Lipids and Lipoproteins in Uraemic Patients
Hörkkö, S., Huttunen, K., Läärä, E., Kervinen, K., & Kesäniemi, Y. A. (1994) · Annals of Medicine · doi:10.3109/07853899409147902 · Cited by 23
Inaccurate Self-Monitoring of Blood Glucose Readings in Patients on Chronic Ambulatory Peritoneal Dialysis with Icodextrin
Pavlicek, V., Garzoni, D., Urech, P., & Brändle, M. (2006) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2006-924011 · Cited by 20
Palliative care in chronic kidney disease: peer mentoring program personalizes advance directives discussions
Perry, E. E., Swartz, J., Kelly, G., Brown, S. L., & Swartz, R. D. (2003) · PubMed · doi:10.25405/ncl.34418574 · Cited by 13
Dietary treatment of blood pressure in kidney disease
Lancaster, K. J. (2004) · Advances in Chronic Kidney Disease · doi:10.1053/j.arrt.2004.01.007 · Cited by 4

Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management
Cappellini, M. D., Comin‐Colet, J., de Francisco, A., Dignass, A., Doehner, W., Lam, C. S., Macdougall, I. C., Rogler, G., Camaschella, C., Kadir, R., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24820 · Cited by 502
Dietary fiber effects in chronic kidney disease: a systematic review and meta-analysis of controlled feeding trials
Chiavaroli, L., Mirrahimi, A., Sievenpiper, J. L., Jenkins, D. J. A., & Darling, P. B. (2015) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.237 · Cited by 170
Association between Drug Insurance Cost Sharing Strategies and Outcomes in Patients with Chronic Diseases: A Systematic Review
Mann, B. S., Barnieh, L., Tang, K., Campbell, D. J. T., Clement, F., Hemmelgarn, B., Tonelli, M., Lorenzetti, D., & Manns, B. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089168 · Cited by 66
Self-citation
Motivational interviewing promotes adherence and improves wellbeing in pre-dialysis patients with advanced chronic kidney disease
García-Llana, H., Remor, E., del Peso, G., Celadilla, O., & Selgas, R. (2014) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-013-9383-y · Cited by 48

See all 420

Authors: Levin, A., Hemmelgarn, B., Culleton, B., Tobe, S., McFarlane, P., Ruzicka, M., Burns, K., Manns, B., White, C., Madore, F., Moist, L., Klarenbach, S., Barrett, B., Foley, R., Jindal, K., Senior, P., Pannu, N., Shurraw, S., Akbari, A., Cohn, A., Reslerova, M., Deved, V., Mendelssohn, D., Nesrallah, G., Kappel, J., Tonelli, M., & for the Canadian Society of Nephrology
Venue: Canadian Medical Association Journal
Publisher: CMA Impact Inc.
Published: 2008-11-18
Volume: 179
Issue: 11
Pages: 1154-1162
ISSN: 0820-3946 (ISSN-L)
1488-2329
DOI: 10.1503/cmaj.080351
OpenAlex: W2156087306
Cited by: 420
References: 334
FWCI: 15.84
Type: journal article
Language: en
Open access: gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Guidelines for the management of chronic kidney disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources